A detailed history of Northern Trust Corp transactions in Incyte Corp stock. As of the latest transaction made, Northern Trust Corp holds 1,545,451 shares of INCY stock, worth $111 Million. This represents 0.02% of its overall portfolio holdings.

Number of Shares
1,545,451
Previous 1,813,119 14.76%
Holding current value
$111 Million
Previous $110 Million 7.06%
% of portfolio
0.02%
Previous 0.02%

Shares

30 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

SELL
$57.33 - $68.61 $15.3 Million - $18.4 Million
-267,668 Reduced 14.76%
1,545,451 $102 Million
Q2 2024

Aug 14, 2024

SELL
$51.18 - $63.75 $1.94 Million - $2.41 Million
-37,848 Reduced 2.04%
1,813,119 $110 Million
Q1 2024

May 14, 2024

SELL
$56.55 - $66.59 $7.38 Million - $8.69 Million
-130,528 Reduced 6.59%
1,850,967 $105 Million
Q4 2023

Feb 13, 2024

SELL
$52.16 - $64.19 $7.63 Million - $9.38 Million
-146,193 Reduced 6.87%
1,981,495 $124 Million
Q3 2023

Nov 13, 2023

BUY
$57.77 - $65.93 $6.9 Million - $7.87 Million
119,389 Added 5.94%
2,127,688 $123 Million
Q2 2023

Aug 11, 2023

SELL
$60.95 - $75.51 $4.48 Million - $5.55 Million
-73,459 Reduced 3.53%
2,008,299 $125 Million
Q1 2023

May 15, 2023

BUY
$70.23 - $86.01 $6 Million - $7.35 Million
85,461 Added 4.28%
2,081,758 $150 Million
Q4 2022

Feb 13, 2023

BUY
$67.18 - $84.11 $4.17 Million - $5.23 Million
62,134 Added 3.21%
1,996,297 $160 Million
Q3 2022

Nov 14, 2022

SELL
$66.18 - $82.86 $4.22 Million - $5.28 Million
-63,738 Reduced 3.19%
1,934,163 $129 Million
Q2 2022

Aug 12, 2022

BUY
$66.18 - $83.18 $1.19 Million - $1.5 Million
18,009 Added 0.91%
1,997,901 $152 Million
Q1 2022

May 13, 2022

SELL
$66.02 - $79.71 $1.79 Million - $2.16 Million
-27,095 Reduced 1.35%
1,979,892 $157 Million
Q4 2021

Feb 08, 2022

BUY
$63.34 - $74.11 $1.61 Million - $1.89 Million
25,489 Added 1.29%
2,006,987 $147 Million
Q3 2021

Nov 15, 2021

BUY
$68.67 - $84.02 $2.81 Million - $3.43 Million
40,880 Added 2.11%
1,981,498 $136 Million
Q2 2021

Aug 13, 2021

SELL
$79.87 - $87.53 $1.52 Million - $1.66 Million
-18,993 Reduced 0.97%
1,940,618 $163 Million
Q1 2021

May 12, 2021

SELL
$76.02 - $100.5 $3.02 Million - $3.99 Million
-39,744 Reduced 1.99%
1,959,611 $159 Million
Q4 2020

Feb 11, 2021

SELL
$80.74 - $97.7 $7.74 Million - $9.37 Million
-95,899 Reduced 4.58%
1,999,355 $174 Million
Q3 2020

Nov 16, 2020

BUY
$85.07 - $109.69 $2.37 Million - $3.06 Million
27,889 Added 1.35%
2,095,254 $188 Million
Q2 2020

Aug 14, 2020

BUY
$74.18 - $108.93 $3.54 Million - $5.19 Million
47,680 Added 2.36%
2,067,365 $215 Million
Q1 2020

May 14, 2020

BUY
$63.18 - $85.97 $2.19 Million - $2.98 Million
34,706 Added 1.75%
2,019,685 $148 Million
Q4 2019

Feb 14, 2020

SELL
$73.04 - $95.72 $7.27 Million - $9.52 Million
-99,471 Reduced 4.77%
1,984,979 $173 Million
Q3 2019

Nov 13, 2019

SELL
$72.82 - $86.52 $4.83 Million - $5.74 Million
-66,295 Reduced 3.08%
2,084,450 $155 Million
Q2 2019

Aug 13, 2019

BUY
$73.52 - $88.7 $9.99 Million - $12.1 Million
135,914 Added 6.75%
2,150,745 $183 Million
Q1 2019

May 13, 2019

BUY
$63.56 - $88.17 $2.63 Million - $3.65 Million
41,396 Added 2.1%
2,014,831 $173 Million
Q4 2018

Feb 12, 2019

BUY
$58.5 - $69.94 $3.68 Million - $4.4 Million
62,842 Added 3.29%
1,973,435 $125 Million
Q3 2018

Nov 14, 2018

SELL
$61.75 - $74.23 $572,731 - $688,483
-9,275 Reduced 0.48%
1,910,593 $132 Million
Q2 2018

Sep 18, 2018

SELL
$60.85 - $83.98 $835,409 - $1.15 Million
-13,729 Reduced 0.71%
1,919,868 $129 Million
Q2 2018

Aug 14, 2018

BUY
$60.85 - $83.98 $3.91 Million - $5.4 Million
64,282 Added 3.44%
1,933,597 $130 Million
Q1 2018

May 09, 2018

BUY
$83.06 - $100.98 $17,276 - $21,003
208 Added 0.01%
1,869,315 $156 Million
Q4 2017

Feb 14, 2018

SELL
$93.56 - $116.6 $2.09 Million - $2.6 Million
-22,296 Reduced 1.18%
1,869,107 $177 Million
Q3 2017

Nov 13, 2017

BUY
$109.15 - $138.27 $206 Million - $262 Million
1,891,403
1,891,403 $221 Million

Others Institutions Holding INCY

About INCYTE CORP


  • Ticker INCY
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 222,431,008
  • Market Cap $16B
  • Description
  • Incyte Corporation, a biopharmaceutical company, focuses on the discovery, development, and commercialization of proprietary therapeutics in the United States and internationally. The company offers JAKAFI, a drug for the treatment of myelofibrosis and polycythemia vera; PEMAZYRE, a fibroblast growth factor receptor kinase inhibitor that act as ...
More about INCY
Track This Portfolio

Track Northern Trust Corp Portfolio

Follow Northern Trust Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Northern Trust Corp, based on Form 13F filings with the SEC.

News

Stay updated on Northern Trust Corp with notifications on news.